According to recent research, astrocyte cell transplantation could revolutionize treatments for neurological disorders such ...

(Image Credits: Pixabay) Parkinson’s disease (PD) therapeutic landscape is heavily genericized, leaving substantial unmet needs in neuroprotective and disease-modifying therapies (DMTs). With current ...

Nilotinib, a blood cancer medicine, was previously shown to improve movement and mental function in a small group of patients ...

Experts made the discovery after analysing hours of YouTube footage of celebrities with the disease - and it paves the way ...

The following column was originally published on Feb. 25, 2022. Thanks to breakthroughs in medicine and nutrition in recent years, we are living longer than ever before. But this increase in life ...

Parkinson’s Disease (PD) is a common brain disorder that affects movement and is most often linked with aging. It’s the second most common age-related brain disease, affecting millions worldwide.

Novo Nordisk (NVO) teased some new details about a potential Ozempic successor during a call with investors Tuesday.

The findings align with an earlier study that showed possible disease-modifying effects of nilotinib in patients with mild ...

Favorable capital market conditions last week enabled the company to raise over $15 million from secondary offerings, and the proceeds allow the Company to fund fully the costs of this upcoming ...

Blind, Randomized, Placebo-controlled, Study of Bezisterim in Subjects with Early Parkinson’s Disease is now fully funded. Favorable capital market conditions last week enabled the company to raise ...

A nationwide charity is welcoming people affected by Parkinson’s for a day of education and bonding. As part of ‘Living well ...